Coretta Campbell

Coretta Campbell serves as a key procurement professional within the W40M MRC0 West agency under the Department of the Army, supporting the mission of sustaining military medical readiness through the acquisition of critical diagnostic, therapeutic, and laboratory capabilities. She manages a portfolio of complex contracts focused on in-vitro diagnostic substances, surgical instruments, sterilization systems, and blood management solutions essential for field-deployable, high-acuity care. Her work ensures the timely delivery of mission-critical medical technologies that enable operational sovereignty across combat and contingency environments, aligning acquisitions with DoD medical readiness standards and clinical requirements. Campbell maintains consistent, long-term relationships with leading medical technology providers including Roche Diagnostics Corporation, Abbott Molecular Inc., Cardinal Health 414, LLC, Surgical Neuromonitoring Associates, Inc., and Premier Shockwave, Inc. These partnerships reflect a preference for established, high-reliability vendors capable of meeting stringent military specifications for sterility, traceability, and rapid deployment. Her contracting approach emphasizes performance-based outcomes, technical compliance, and supply chain resilience, often leveraging blanket purchase agreements and indefinite-delivery/indefinite-quantity contracts to ensure continuous availability of life-saving medical assets. Campbell’s procurement activity is entirely non-set-aside, with 100% of awards issued under full and open competition. This reflects a strategic prioritization of technical capability, regulatory compliance, and operational readiness over socioeconomic set-asides, ensuring access to the most advanced and mission-proven medical technologies available in the commercial market. Her primary procurement focus lies in NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing) and NAICS 339112 (Surgical and Medical Instrument Manufacturing), indicating deep expertise in molecular diagnostics, point-of-care testing reagents, sterile surgical kits, and minimally invasive instrument systems. She specializes in acquiring products that meet FDA-cleared and military-specific standards, with an emphasis on technologies that support trauma care, infectious disease detection, and surgical precision in austere environments.